The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Open accessAbstract
Pancreatic endocrine tumors (PETs) have long fascinated clinicians and investigators despite their relative rarity. Their clinical presentation varies depending upon whether the tumor is functional or not and also according to the specific hormonal syndrome produced. Tumors may be sporadic or inherited but little is known about their molecular pathology, especially the sporadic forms. Chromogranin A appears to be the most useful serum marker for diagnosis, staging and monitoring. Initially, therapy should be directed at the hormonal syndrome as this has the major initial impact on the patient's health. Most PETs are relatively indolent but ultimately malignant, except for insulinomas which are predominantly benign. Surgery is the only modality that offers the possibility of cure although it is generally noncurative in patients with Zollinger-Ellison syndrome or nonfunctional PETs with MEN1. Preoperative staging of disease extent is necessary to determine the likelihood of complete resection though debulking surgery is often felt to be useful in unresectable patients. Once metastatic, biotherapy is usually the first modality employed because it is generally well tolerated. Systemic or regional therapies are generally reserved until symptoms occur or tumor growth is rapid. Recently a number of newer agents, as well as receptor-directed radiotherapy, are being evalulated for patients with advanced disease. This review addresses a number of recent advances regarding the molecular pathology, diagnosis, localization and management of PETs including discussion of peptide receptor radionuclide therapy and other novel antitumor approaches. We conclude with a discussion of future directions and unsettled problems in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Gastrinomas: A 42‐year experience
Kaplan, E. L., Horvath, K., Udekwu, A. O., Straus, F. H., Schark, C., Ferguson, D. J., & Skinner, D. B. (1990) · World Journal of Surgery · doi:10.1007/bf01658530 · Cited by 49
ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
Perry, R. R., & Vinik, A. I. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.57 · Cited by 49
Vezzosi, D., Bennet, A., Fauvel, J., Boulanger, C., Tazi, O., Jp, L., & Caron, P. J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490413 · Cited by 49
Metastatic gastrinomas: localization with selective arterial injection of secretin.
Gibril, F., Doppman, J. L., Chang, R., Weber, H. C., Termanini, B., & Jensen, R. T. (1996) · Radiology · doi:10.1148/radiology.198.1.8539410 · Cited by 48
Self-citationAblative Therapies for Liver Metastases of Gastroenteropancreatic Endocrine Tumors
Ruszniewski, P. B., & O’Toole, D. (2004) · Neuroendocrinology · doi:10.1159/000080746 · Cited by 46
Aetiology, molecular pathogenesis and genetics
Rindi, G., & Bordi, C. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.03.005 · Cited by 46
Cougard, P., Goudet, P., Peix, J. L., Henry, J. F., Sarfati, E., Proye, C. A. G., & Calender, A. (2000) · Annales de Chirurgie · doi:10.1016/s0001-4001(00)00112-4 · Cited by 44
Advances in Gastric Antisecretory Therapy in Zollinger-Ellison Syndrome
Metz, D. C., & Jensen, R. T. (2015) · Frontiers of gastrointestinal research · doi:10.1159/000423503 · Cited by 42
Self-citationSchillaci, O., Corleto, V. D., Annibale, B., et al. (1999) · PubMed · Cited by 40
Sampling Strategies for Analysis of Enterochromaffin-like Cell Changes in Zollinger-Ellison Syndrome
Bordi, C., Azzoni, C., Ferraro, G., Corleto, V. D., Gibril, F., Fave, G. D., Lubensky, I. A., Venzon, D. J., & Jensen, R. T. (2000) · American Journal of Clinical Pathology · doi:10.1093/ajcp/114.3.419 · Cited by 38
Self-citationCurative Resection of Microgastrinomas Based on the Intraoperative Secretin Test
Kato, M., Imamura, M., Hosotani, R., Shimada, Y., Doi, R., Itami, A., Komoto, I., KOSAKA, T., & Konishi, J. (2000) · World Journal of Surgery · doi:10.1007/s002680010235 · Cited by 38
Gastroenteropancreatic endocrine tumors: clinical characterization before therapy
Baudin, É. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0425 · Cited by 37
A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours
Strosberg, J., & Kvols, L. K. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.219 · Cited by 36
Imaging for Pancreatic Endocrine Tumor Localization: Recent Advances
Orbuch, M., Doppman, J. L., Strader, D. B., Fishbeyn, V. A., Benya, R. V., Metz, D. C., & Jensen, R. T. (2015) · Frontiers of gastrointestinal research · doi:10.1159/000423505 · Cited by 36
Self-citationKwekkeboom, D. J., Teunissen, J. J. M., Kam, B. L. R., Valkema, R., de Herder, W. W., & Krenning, E. P. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.009 · Cited by 35
Management of metastatic endocrine tumours
Plöckinger, U., & Wiedenmann, B. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.013 · Cited by 34
Termanini, B., Gibril, F., Doppman, J. L., Reynolds, J. C., Stewart, C. A., Sutliff, V. E., Venzon, D. J., & Jensen, R. T. (1997) · Radiology · doi:10.1148/radiology.202.1.8988205 · Cited by 33
Self-citationSamyn, I., Fontaine, C., van Tussenbroek, F., Pipeleers‐Marichal, M., & Grève, J. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.031 · Cited by 33
Wald, M., Lawrenz, K., Luckner, D., Seimann, R., Mohnike, K. L., & Schober, E. (2002) · European Journal of Pediatrics · doi:10.1007/s00431-002-1022-9 · Cited by 31
Case, C. C., & Vassilopoulou‐Sellin, R. (2003) · Endocrine Practice · doi:10.4158/ep.9.1.22 · Cited by 29
Hou, W., & Schubert, M. L. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000245538.43142.87 · Cited by 22
Non-functioning tumours of the pancreas in MEN1 patients.
Triponez, F., & Cadiot, G. (2007) · PubMed · Cited by 14
Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options
Pausawasdi, N., & Scheiman, J. M. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282ba5713 · Cited by 13
Cited by
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationNANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Self-citationIto, T., Igarashi, H., Nakamura, K., Sasano, H., Okusaka, T., Takano, K., Komoto, I., Tanaka, M., Imamura, M., Jensen, R. T., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0934-2 · Cited by 405
Self-citationEpidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan
Ito, T., Sasano, H., Tanaka, M., Osamura, R. Y., Sasaki, I., Kimura, W., Takano, K., Obara, T., Ishibashi, M., Nakao, K., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-009-0194-8 · Cited by 394
Self-citationIto, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Self-citation
Metadata
- Authors
- Metz, D. C., & Jensen, R. T.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 135
- Issue
- 5
- Pages
- 1469-1492
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2002575907
- Cited by
- 816
- References
- 223
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.